back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-09-06 12:02 Tx date 2019-09-06 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
37 - Stock split or consolidation
|
-214,030 vol |
209 | |
| Filed 2019-09-04 16:58 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-31,950
-22,500 vol $1.42 each |
214,239 | |
| Filed 2019-09-04 16:57 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-12,168
-31,200 vol $0.39 each |
236,739 | |
| Filed 2019-06-22 12:47 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
57 - Exercise of rights
|
$-454.9816
-29,933 vol $0.0152 each |
0 | |
| Filed 2019-06-22 12:34 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,099
+598,660 vol $0.0152 each |
913,101 | |
| Filed 2019-06-22 12:29 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
56 - Grant of rights
|
$454.98
+29,933 vol $0.0152 each |
29,933 | |
| Filed 2019-06-22 12:28 Tx date 2016-08-10 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-22 12:24 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-122,000
-50,000 vol $2.44 each |
9,375,000 | |
| Filed 2019-06-22 12:23 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-105,000
-35,000 vol $3.00 each |
9,425,000 | |
| Filed 2019-06-22 12:22 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-93,150
-45,000 vol $2.07 each |
9,460,000 | |
| Filed 2019-06-22 12:21 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-90,090
-117,000 vol $0.77 each |
9,505,000 | |
| Filed 2019-06-22 12:20 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$84,375
+3,125,000 vol $0.027 each |
9,622,000 | |
| Filed 2019-06-22 12:19 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$168,750
+6,250,000 vol $0.027 each |
6,497,000 | |
| Filed 2019-06-10 16:45 Tx date 2019-05-27 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-52,800
-48,000 vol $1.10 each |
247,000 | |
| Filed 2019-05-31 15:26 Tx date 2019-05-30 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-85,782
-295,800 vol $0.29 each |
267,939 | |
| Filed 2019-02-06 Tx date 2019-02-01 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,782
+295,800 vol $0.29 each |
563,739 | |
| Filed 2019-02-06 Tx date 2018-12-31 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-80,073
-27,900 vol $2.87 each |
267,939 | |
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$48,672
+124,800 vol $0.39 each |
295,839 | |
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
||
| Filed 2018-12-17 Tx date 2018-12-14 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-20,000
-50,000 vol $0.40 each |
295,000 |